|
|
|
|||||||
|
|||||||||
J Biol Chem, Vol. 274, Issue 14, 9778-9785, April 2, 1999
From the § Department of Microbiology, Colorado State
University, Fort Collins, Colorado 80523 and the
Members of the Mycobacterium avium
complex are the most frequently encountered opportunistic bacterial
pathogens among patients in the advanced stage of AIDS. Two clinical
isolates of the same strain, numbers 397 and 417, were obtained from an
AIDS patient with disseminated M. avium complex infection
before and after treatment with a regimen of clarithromycin and
ethambutol. To identify the biochemical consequence of drug treatment,
the expression and chemical composition of their major cell wall
constituents, the arabinogalactan, lipoarabinomannan, and the surface
glycopeptidolipids (GPL), were critically examined. Through thin layer
chromatography, mass spectrometry, and chemical analysis, it was found
that the GPL expression profiles differ significantly in that several
apolar GPLs were overexpressed in the clinically resistant 417 isolate at the expense of the serotype 1 polar GPL, which was the single predominant band in the ethambutol-susceptible 397 isolate. Thus, instead of additional rhamnosylation on the 6-deoxytalose (6-dTal) appendage to give the serotype 1-specific disaccharide hapten, the
accumulation of this nonextended apolar GPL probably provided more
precursor substrate available for further nonsaccharide substitutions including a higher degree of O-methylation to give
3-O-Me-6-dTal and the unusual 4-O-sulfation on
6-dTal. Further data showed that this alteration effectively
neutralized ethambutol, which is known to inhibit arabinan synthesis.
Thus, in contrast with derived Emb-resistant mutants of
Mycobacterium smegmatis or Mycobacterium tuberculosis, which are devoid of a surface GPL layer, the
lipoarabinomannan from resistant 417 isolate grown in the presence of
this drug was not apparently truncated.
Altered Expression Profile of the Surface Glycopeptidolipids in
Drug-resistant Clinical Isolates of Mycobacterium avium
Complex
,, and Institute of Biological Chemistry, Academia Sinica,
Nankang, Taipei 115, Taiwan, Republic of China
Copyright © 1999 by The American Society for Biochemistry and Molecular Biology, Inc.
CiteULike 
Complore 
Connotea 
Del.icio.us 
Digg 
Reddit 
Technorati What's this?
This article has been cited by other articles:
|
|
 |
|
  J. S Schorey and L. Sweet The mycobacterial glycopeptidolipids: structure, function, and their role in pathogenesis Glycobiology, November 1, 2008; 18(11): 832 - 841. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. Fujiwara, N. Nakata, T. Naka, I. Yano, M. Doe, D. Chatterjee, M. McNeil, P. J. Brennan, K. Kobayashi, M. Makino, et al. Structural Analysis and Biosynthesis Gene Cluster of an Antigenic Glycopeptidolipid from Mycobacterium intracellulare J. Bacteriol., May 15, 2008; 190(10): 3613 - 3621. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. Nakata, N. Fujiwara, T. Naka, I. Yano, K. Kobayashi, and S. Maeda Identification and Characterization of Two Novel Methyltransferase Genes That Determine the Serotype 12-Specific Structure of Glycopeptidolipids of Mycobacterium intracellulare J. Bacteriol., February 1, 2008; 190(3): 1064 - 1071. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. Fujiwara, N. Nakata, S. Maeda, T. Naka, M. Doe, I. Yano, and K. Kobayashi Structural Characterization of a Specific Glycopeptidolipid Containing a Novel N-Acyl-Deoxy Sugar from Mycobacterium intracellulare Serotype 7 and Genetic Analysis of Its Glycosylation Pathway J. Bacteriol., February 1, 2007; 189(3): 1099 - 1108. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. Sweet and J. S. Schorey Glycopeptidolipids from Mycobacterium avium promote macrophage activation in a TLR2- and MyD88-dependent manner J. Leukoc. Biol., August 1, 2006; 80(2): 415 - 423. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. D. Mougous, R. H. Senaratne, C. J. Petzold, M. Jain, D. H. Lee, M. W. Schelle, M. D. Leavell, J. S. Cox, J. A. Leary, L. W. Riley, et al. A sulfated metabolite produced by stf3 negatively regulates the virulence of Mycobacterium tuberculosis. PNAS, March 14, 2006; 103(11): 4258 - 4263. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Mukherjee, M. Gomez, N. Jayaraman, I. Smith, and D. Chatterji Hyperglycosylation of glycopeptidolipid of Mycobacterium smegmatis under nutrient starvation: structural studies Microbiology, July 1, 2005; 151(7): 2385 - 2392. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Burguiere, P. G. Hitchen, L. G. Dover, A. Dell, and G. S. Besra Altered expression profile of mycobacterial surface glycopeptidolipids following treatment with the antifungal azole inhibitors econazole and clotrimazole Microbiology, June 1, 2005; 151(6): 2087 - 2095. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. Krzywinska, J. Krzywinski, and J. S. Schorey Phylogeny of Mycobacterium avium strains inferred from glycopeptidolipid biosynthesis pathway genes Microbiology, June 1, 2004; 150(6): 1699 - 1706. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. D. Mougous, M. D. Leavell, R. H. Senaratne, C. D. Leigh, S. J. Williams, L. W. Riley, J. A. Leary, and C. R. Bertozzi Discovery of sulfated metabolites in mycobacteria with a genetic and mass spectrometric approach PNAS, December 24, 2002; 99(26): 17037 - 17042. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Kr. Ojha, S. Varma, and D. Chatterji Synthesis of an unusual polar glycopeptidolipid in glucose-limited culture of Mycobacterium smegmatis Microbiology, October 1, 2002; 148(10): 3039 - 3048. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. J. Williams, R. H. Senaratne, J. D. Mougous, L. W. Riley, and C. R. Bertozzi 5'-Adenosinephosphosulfate Lies at a Metabolic Branch Point in Mycobacteria J. Biol. Chem., August 30, 2002; 277(36): 32606 - 32615. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |